Archives

by in
Entry Author Date Location
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
Shire Pays Over $260M Upfront in IPO Detour for San Diego’s Lumena 05/12/14 National
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Zafgen Lines Up $86M IPO to Bankroll Obesity Drug Push 04/20/14 Boston
San Diego’s Lumena Files for IPO to Fund Liver Drug Trials 04/04/14 San Diego
San Diego Life Sciences Roundup: Zogenix, Ignyta, AnaptysBio, & More 03/17/14 San Diego
Lumena Pharmaceuticals Receives $45,000,000 Series B Financing Round 03/11/14 San Diego
ZS Pharma Raises $55M to Develop Drug to Treat Hyperkalemia 03/06/14 Texas
ZS Pharma Secures $55,000,000 Series D Financing Round 03/06/14 Texas
Lithera Raises Additional $8M for Injectable Drug to Melt Belly Fat 02/18/14 San Diego
Lithera Garners $8,000,000 Series C Financing 02/12/14 San Diego
Sutro Biopharma Garners $26,000,000 Series D Funding 12/11/13 San Francisco
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Zafgen Corrals $45M More to Fuel Obesity Drug Push 12/04/13 Boston
Zafgen Secures $45,000,000 Series E Financing Round 12/04/13 Boston
ZS Pharma Passes Key Test With Drug for Hyperkalemia 11/20/13 Texas
Immune Design Garners $49,000,000 Series C Financing 10/30/13 Seattle
Aerie Gets Lukewarm Reception, Cuts IPO Price to $10 Per Share 10/25/13 New York
Aerie Pharma Eyes $58M IPO For Glaucoma Drug Push 09/18/13 New York
After Raising $59M, aTyr Plans Physiocrines Proof-of-Concept Trials 07/29/13 San Diego
aTyr Pharma Secures $49,000,000 New Financing 07/29/13 San Diego
Zafgen’s Obesity Drug Continues to Cut The Fat in Phase 2 Trial 06/22/13 Boston
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Kite Pharma Obtains $20,000,000 Series A Funding 05/15/13 San Diego
Esperion Therapeutics Secures $33,000,000 New Funding Round 04/25/13 Detroit
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Allakos Receives $32,000,000 Series A Funding Round 12/18/12 San Francisco
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
Zafgen Obtains $21,000,000 New Funding Round 12/04/12 Boston
ZS Pharma Receives $46,000,000 Series C Funding Round 10/26/12 Texas
Page 1 of 4 next page »